Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQ1W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,239
Award facts
- Contract value 100% obligated
- $20,239.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,239.36 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in a 2-pen/mL configuration. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025, and was awarded on September 8, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement designated SPE2DX and running through December 2026, which enables comprehensive pharmaceutical support across military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through competitively awarded contracts with the Defense Logistics Agency and its medical supply chain. The company's extensive federal contract portfolio encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. As a child contract under the larger global pharmaceutical support vehicle, this delivery order supports military healthcare programs and demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements on an ongoing basis through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FQ1W7?
SPE2DB25FQ1W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FQ1W7 worth?
The government has obligated $20,239 on SPE2DB25FQ1W7.
Is contract SPE2DB25FQ1W7 an order under another contract?
Yes. SPE2DB25FQ1W7 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ1W7 competed?
The extent of competition for SPE2DB25FQ1W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award